Drugmakers

• Ozempic among ‘bogus’ drug patents being challenged by U.S. to spur competition

  The Federal Trade Commission sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions.

  Health

  Apr 30
  
• Giant heroin spoon sculpture appears outside offices of Rhode Island-based pharmaceutical company

  Artist Domenic Esposito is protesting the opioid crisis by placing a giant sculpture of a burnt spoon in front of the offices of a Rhode Island pharmaceutical company.

  Health

  Feb 8, 2019
  
• Advertisement
• Price shaming: Health advocates hope new legislation keeps drug prices low

  Frustrated by the rising cost of prescription drugs, California health advocates hope sunlight and a dose of shame will discourage drugmakers from raising their prices too quickly.

  Consumer

  Jul 10, 2016
• Advertisement
• Martin Shkreli’s price increase strategy not uncommon for drug distributors

  The strategy takes advantage of a simple fact: If generic drugmakers can't get their hands on the original product, they cannot perform the tests needed to develop a generic version.

  Consumer

  Mar 3, 2016